Comparison of two kits of anti-infliximab antibodies plasmatic measurement.

CONCLUSION: The assessment of the performance of the tested microplate reader and the validation of the tested ELISA kit showed good results allowing ATI routine measurement to optimize therapeutic management of patients treated by IFX.
PMID: 31418707 [PubMed - in process]

Source: Annales de Biologie Clinique - July 31, 2019 Category: Biochemistry Authors: Charfi R, Mahmoud I, Ben Salem F, Moalla M, Bouden S, Sfar I, Saïdane O, Klouz A, Daghfous R, Gorgi Y, Abdelmoula L, Trabelsi S Tags: Ann Biol Clin (Paris) Source Type: research